Emily Richardson joins Cannalysis as the Vice President of Strategic Development, bringing nearly a decade of experience in the Cannabis testing industry. She previously worked at CW Analytical Laboratories, where she oversaw all aspects of business development, client relations and regulatory engagement. She is passionate about supporting industry stakeholders as they navigate quality assurance and regulatory frameworks to create Cannabis products that are safe, consistent and compliant.